IPO GMP: Meaning, Risks & Why Not to Rely On

What Is the Grey Market and How Did It Develop in India?

To understand GMP, you first need to understand the grey market itself. The term "grey market" in the context of Indian IPOs refers to an informal, peer-to-peer market where IPO applications and allotted shares are bought and sold before the official listing date. It is called "grey" because it exists in a legal grey zone - it is not explicitly prohibited by a specific statute in the way that a "black market" activity might be, but it is also entirely unregulated and unrecognised by SEBI, NSE, or BSE.

The grey market in India is not a physical place or an organised exchange. It is a network of dealers, often called grey market operators, who connect buyers and sellers. Transactions happen over phone calls, messaging apps, and through trusted intermediaries in financial hubs. Cities like Ahmedabad, Mumbai, and Rajkot have historically been known centres for grey market activity in India, though the internet has made it geographically dispersed.

Historically, the grey market developed because there was a natural information and liquidity gap between the time an investor applied for an IPO and the time the shares actually appeared in their demat account and started trading. An investor who was confident about the listing prospects of a particular IPO wanted a way to lock in a profit before listing, while another investor who missed the subscription window wanted a way to participate in an expected listing pop. The grey market filled this gap.

There are broadly two types of transactions in the grey market. The first involves buying and selling IPO applications themselves - an investor who has applied for shares sells their entire application to a grey market operator at a premium, before allotment is even announced. The second, more common type involves the notional buying and selling of shares based on the expectation of what price they will trade at after listing. For example, if an IPO has a price band of ₹200–₹210 and GMP is ₹150, it means grey market participants are willing to transact at ₹360 (₹210 + ₹150), implying they expect the listing price to be around that level.

It is critically important to understand that these transactions are settled informally, based entirely on mutual trust between the parties. There is no exchange, no clearing house, no settlement mechanism, and no legal recourse if one party defaults. If the grey market operator disappears, or if the listing price comes in far below the agreed grey market price, the losing party has no formal avenue for recovery. Courts have generally been reluctant to enforce contracts relating to grey market transactions precisely because of their extralegal nature.

The rise of social media and financial influencer culture in India after 2019 amplified the grey market's visibility enormously. What was once a niche activity among experienced traders became mainstream retail investor conversation. GMP figures began to be published on websites and Telegram channels as though they were official data points, giving new investors a false sense of accuracy and reliability. Many retail investors, seeing a high GMP, would interpret it as a guaranteed listing gain and apply for IPOs purely on the basis of this figure, without reading the DRHP (Draft Red Herring Prospectus) or analysing the company's financials at all.

How Is GMP Calculated and Quoted?

GMP is not calculated through any formal mathematical model. It is, at its core, a market-discovered price that emerges from the collective buying and selling intentions of grey market participants. However, there are some conventional ways in which it is expressed and interpreted, and understanding these will help you decode the numbers you see quoted online.

The most common expression of GMP is as an absolute rupee premium over the IPO's upper price band (the cut-off price). For example, if an IPO has an upper price band of ₹500 and the GMP is quoted as ₹200, it implies that grey market participants are transacting at ₹700, and the implied listing price expectation is ₹700 on the NSE or BSE.

Sometimes GMP is also expressed as a percentage. In the above example, a ₹200 GMP on a ₹500 issue price would be a 40% GMP, implying a 40% expected listing gain. Many financial websites publish GMP in both absolute and percentage terms.

There is also a concept called "Kostak rate" in the grey market, which is distinct from GMP. The Kostak rate refers to the price at which a grey market operator is willing to buy an entire IPO application from an applicant, regardless of whether that applicant receives an allotment. For instance, if the Kostak rate is ₹2,000 per application, it means a grey market operator will pay ₹2,000 to take over your application - so if you applied for one lot of an IPO worth ₹15,000, you would receive your ₹15,000 back (effectively, since the operator takes the application and its associated ASBA block) plus ₹2,000 in profit, regardless of the outcome. This is a way for retail investors to lock in a guaranteed (though grey market) profit from their application.

Another related term is "Subject to Sauda" (STS), which refers to deals contingent on allotment. In an STS deal, the grey market premium is paid only if the applicant actually receives an allotment. If there is no allotment, the deal is void.

Who decides the GMP figure? Grey market operators in major financial centres aggregate demand and supply information from their networks and set a "market price" for the IPO shares. This price is influenced by factors such as the perceived quality of the company, subscription numbers (especially from QIBs and NIIs), broader market conditions, sector sentiment, news flow about the company, and pure speculative momentum. There is no central authority - different grey market operators may quote slightly different GMPs, and the figure can change multiple times during a single day, especially in the days immediately before listing.

Because GMP is set by a small, informal network of operators rather than by a broad, transparent market with millions of participants, it is susceptible to manipulation. An operator who has taken a large position at a certain price has an incentive to quote a high GMP to attract more buyers and drive up the informal market price. This is a key reason why GMP can be misleading - it may reflect the positioning of a few influential grey market players rather than genuine broad-based investor sentiment.

For retail investors reading GMP figures on websites, it is important to know that these websites are simply aggregating self-reported data from grey market operators and community members. There is no audit, no verification, and no accountability. The figures are, at best, indicative and, at worst, deliberately inflated.

The Mechanics of Grey Market Transactions in India

Understanding how grey market transactions actually work in practice helps demystify the process and also illustrates why the risks are so significant. Let us walk through the typical mechanics step by step.

When an IPO opens for subscription, grey market operators begin quoting a GMP almost immediately - sometimes even before the subscription window opens, based on the DRHP and pre-IPO buzz. As subscription data flows in (SEBI mandates real-time disclosure of subscription figures on NSE and BSE), the GMP is updated to reflect the emerging picture of demand.

A retail investor who wants to "lock in" gains applies for the IPO through the regular ASBA or UPI mechanism on their broker's platform. Simultaneously, they contact a grey market operator (usually through referrals or Telegram groups) and enter into a verbal or message-based agreement to sell their expected allotment at a specific price. For example, if the issue price is ₹400 and GMP is ₹120, they agree to sell the shares at ₹520 on the listing day.

If the investor receives an allotment, they are expected to either transfer the shares to the buyer through a pool account arrangement on the listing day or settle the price difference in cash. If the listing price exceeds ₹520, the grey market buyer profits. If the listing price is below ₹520, the buyer makes a loss. The seller has locked in ₹520 regardless of the market outcome.

Here is where the risk intensifies. There is no formal contract, no stamp duty paid on the agreement (which would make it legally enforceable in India), and no escrow mechanism protecting either party. If the listing price collapses - say to ₹350 - the buyer who agreed to pay ₹520 may simply refuse to honour the deal, leaving the seller with shares they did not want to hold, at a price lower than they expected. Conversely, if the listing price surges to ₹700, the grey market seller might be tempted to renege and sell in the open market instead.

For the Kostak-type transactions, where an operator buys the entire application before allotment, the risk for the operator is allotment risk and listing risk combined. If subscription is very high and allotment is tiny, the operator has paid a premium for applications that yield very few shares. If the listing price is then lower than expected, the operator can take a significant loss.

From a regulatory standpoint, SEBI has consistently cautioned investors against participating in grey market transactions. SEBI's investor education materials explicitly state that grey market activities are outside its regulatory purview and that investors have no recourse to SEBI's grievance redressal mechanisms (such as SCORES) for grey market disputes. The exchanges - NSE and BSE - similarly do not recognise or facilitate grey market transactions.

It is also worth noting that grey market transactions can have income tax implications. Profits from grey market dealings are taxable as income in India, though the informal nature of these transactions means many participants do not report them. Investors should consult a qualified tax professional about the tax treatment of any grey market profits or losses, keeping in mind the applicable provisions of the Income Tax Act and the latest Finance Act.

What Drives GMP Up or Down?

Since GMP is a product of informal market sentiment, a wide range of factors can push it higher or lower. Understanding these drivers helps explain why GMP can be volatile and why it does not necessarily correlate with the fundamental quality of the IPO or the listing outcome.

The single largest driver of GMP in recent Indian IPO history has been oversubscription levels, particularly from the QIB (Qualified Institutional Buyers) and NII (Non-Institutional Investors, i.e., HNIs) categories. When an IPO attracts massive oversubscription - say 50x, 100x, or even 300x in the NII category - it signals strong perceived demand, and grey market operators take this as a cue to push GMP higher. The logic is intuitive: if so many investors want in, the listing demand should be high. However, much of the NII oversubscription in Indian IPOs is driven by borrowed money (leveraged applications), and these investors are quick to sell on listing day, which can actually depress the listing price.

Broader market conditions are another major driver. When Nifty 50 and Sensex are on a strong bull run, GMP across most IPOs tends to be elevated because sentiment is positive and investors expect momentum to carry through to listings. During bear phases or periods of high volatility - such as when the Nifty sees sharp corrections - GMPs can collapse rapidly, even for reasonably good companies.

Sector sentiment plays a significant role as well. If the market is rewarding technology companies, defence companies, or infrastructure companies with high valuations, IPOs from those sectors will typically command higher GMPs. This is not necessarily related to the specific company's quality but rather to the sector rotation and thematic investing trends in the broader market.

Newsflow about the company - positive media coverage, analyst commentary, or buzz on social media - can drive GMP higher. Conversely, negative news about the promoter group, regulatory issues, or a poor analyst review of the DRHP can cause GMP to fall. Since grey market participants are often not sophisticated fundamental analysts, they respond strongly to news momentum, which can create exaggerated GMP moves in either direction.

The pricing of the IPO relative to listed peers is also a factor. If the IPO is priced at a significant discount to comparable listed companies, grey market participants see room for re-rating, and GMP tends to be higher. If the IPO is aggressively priced (meaning it already prices in most of the growth expectations), GMP may be lower or can collapse closer to listing as participants reassess.

Finally, the absolute lot size and the retail investor quota allocation influence GMP dynamics. When the minimum application amount is relatively low and the retail quota is substantial, more retail participants can apply, which creates broader grey market activity and can amplify GMP movements.

It is important to appreciate that all these drivers are sentiment-based. None of them directly measure the long-term intrinsic value of the business being offered. A company could have an excellent balance sheet, strong earnings growth, and a reasonable valuation - and still see low GMP because it is in an unfashionable sector. Conversely, a loss-making company in a hyped sector could show sky-high GMP. GMP measures the market's excitement, not the business's quality.

Why GMP Is an Unreliable Predictor of Listing Price

This is perhaps the most important section of this entire guide, because the most common - and most dangerous - use of GMP among retail investors is as a prediction of listing price. The evidence, both from academic research and from observed Indian IPO data, strongly suggests that GMP is an unreliable predictor of listing performance, particularly for retail investors making financial decisions based on it.

First, let us understand the fundamental problem of information asymmetry. The grey market is dominated by a small group of operators and their networks who have both the resources to track subscription data in real time and the experience to interpret it. Retail investors accessing GMP figures through websites and social media are at the end of an information chain - they are seeing numbers that have already been processed, possibly inflated, and filtered through multiple intermediaries. By the time a retail investor reads a GMP figure and decides to apply for an IPO based on it, the information has already been traded upon by those closer to the grey market.

Second, GMP is extraordinarily volatile in the days leading up to listing. It is not uncommon for GMP to be ₹200–₹300 a week before listing and then fall to ₹50–₹80 by the day before listing, only to see the stock actually list at par or at a loss. The reasons for this collapse can include deteriorating market conditions, negative news about the sector, large institutional investors (who were allocated shares in the anchor or QIB round) signalling their intention to sell on listing day, or simply grey market operators unwinding their positions. None of these signals are visible to a retail investor who checked GMP once a week ago and assumed it was a stable indicator.

Third, there is the phenomenon of "GMP manipulation" that is widely discussed among informed market participants. Since GMP is self-reported and there is no verification mechanism, operators who have taken positions can benefit from quoting higher GMPs to attract more buyers, thereby creating a self-reinforcing spiral of sentiment. When the listing day arrives and the actual price discovery process happens on NSE and BSE under the watchful eye of millions of real buyers and sellers, the true valuation often diverges significantly from the inflated grey market expectation.

Fourth, the listing day dynamics in Indian markets involve forces that grey market pricing cannot fully account for. Anchor investors - large institutional investors allotted shares before the IPO opens - are subject to a 30-day lock-in on half their allotment (as per SEBI's current regulations; always verify the latest rules). The moment the lock-in expires, institutional selling pressure can emerge. Similarly, promoters and pre-IPO investors have their own lock-in periods, and their eventual selling (often called "overhang") can weigh on the stock post-listing. None of this is reflected in GMP.

Fifth, GMP says nothing about what happens after the listing day. Even if GMP correctly predicts a strong listing pop, the stock could then fall sharply in the weeks following listing as the initial enthusiasm fades, lock-in periods expire, and the business fundamentals reassert themselves as the primary driver of valuation. Many Indian IPOs that listed at significant premiums have subsequently traded below their issue price for extended periods. Investors who relied on GMP to apply, and who chose to hold the stock after listing, often found themselves sitting on losses.

The bottom line is straightforward: GMP is a real-time snapshot of speculative sentiment in an unregulated market. It can sometimes point in the right direction, much like any sentiment indicator occasionally does. But it is not a reliable, consistent, or safe basis for making investment decisions.

The Regulatory Landscape: Where SEBI Stands on Grey Markets

SEBI, India's capital markets regulator, has a clear and consistent position on grey market activities: they are outside its regulatory framework and investors participating in them do so entirely at their own risk. This is an important distinction that every retail investor should internalise.

SEBI's role is to regulate the formal securities market - the IPO process, the listing and trading of securities on recognised stock exchanges (NSE, BSE, Metropolitan Stock Exchange), brokers and intermediaries registered with it, and investor grievance redressal through its SCORES (SEBI Complaint Redress System) platform. Grey market transactions do not happen on recognised exchanges, do not involve SEBI-registered intermediaries in their grey market capacity, and are therefore entirely outside SEBI's jurisdiction.

This means that if you enter a grey market transaction and your counterpart defaults - whether they are a grey market operator or another retail investor - SEBI cannot help you. You cannot file a complaint on SCORES. The exchanges cannot intervene. Your only recourse would be through civil courts, and as noted earlier, the extralegal nature of grey market agreements makes enforcement extremely difficult.

SEBI has over the years issued various investor education circulars and warnings specifically mentioning the risks of grey market participation. The regulator's consistent message is that investors should base their IPO investment decisions on the DRHP and the Red Herring Prospectus, which companies are mandated to file and make publicly available. These documents contain extensive disclosures about the company's financials, business risks, objects of the issue, and promoter background - all of which are far more relevant to long-term investment outcomes than a speculative GMP figure.

From a broader regulatory perspective, it is worth noting that SEBI has been progressively tightening IPO regulations over the years to improve price discovery and protect retail investors. Measures such as mandatory UPI-based applications for retail investors (which speeds up refunds and reduces the capital blocked in applications), T+6 listing timelines (which SEBI reduced to T+3 in 2023 to further shorten the gap between issue closing and listing, reducing grey market exposure windows), and enhanced disclosures for SME IPOs are all aimed at making the formal IPO process more efficient and transparent.

The move to T+3 listing timelines (where T is the issue closing date) is particularly relevant to the grey market discussion. The shorter the gap between subscription closing and listing, the less time there is for grey market activity to build momentum and for GMP figures to diverge meaningfully from eventual listing prices. SEBI's regulatory direction is thus, in part, aimed at reducing the influence and relevance of the grey market, even if not directly prohibiting it.

Investors should also be aware that income earned through grey market transactions is taxable under Indian income tax law. The characterisation of such income - whether as capital gains or business income - depends on the frequency and nature of the transactions. Given that grey market transactions are rarely documented, investors who participate may face difficulties in accurate tax reporting. Consulting a qualified chartered accountant or tax advisor and referring to the latest Finance Act is strongly recommended before engaging in any grey market activity.

What You Should Analyse Instead of GMP

If GMP is unreliable, what should retail investors actually focus on when evaluating an IPO? This section provides a structured framework for IPO analysis that is grounded in publicly available, regulated information rather than speculative sentiment.

The starting point for any serious IPO analysis is the Draft Red Herring Prospectus (DRHP) and the final Red Herring Prospectus (RHP). These documents, filed with SEBI and available on the SEBI website as well as the IPO's official website, contain comprehensive information about the company. Reading at least the key sections - objects of the issue, company overview, financial statements, risk factors, and management discussion and analysis - gives you a far more informed basis for a decision than any GMP figure can.

The objects of the issue section tells you what the company plans to do with the money raised. Is it using IPO proceeds to fund growth (expansion of capacity, new product development, geographic expansion)? Or is a large portion of the IPO an Offer for Sale (OFS), where existing shareholders sell their stake and the company receives no money? A large OFS component can be a red flag because it may indicate that promoters and early investors are cashing out rather than investing in the business's future.

Financial analysis is essential. Key metrics to examine include revenue growth over three to five years, profitability trends (particularly at the EBITDA and net profit levels), return on equity (ROE) and return on capital employed (ROCE), debt levels relative to equity and earnings (net debt-to-EBITDA), and cash flow from operations. A business that is profitable, growing, and generating free cash flow is on a fundamentally sounder footing than one that is growing rapidly but burning cash.

Valuation comparison is crucial. The price-to-earnings (P/E) ratio of the IPO at the issue price should be compared with listed peers in the same sector. If the IPO is priced at a significant premium to peers without a clear justification (such as higher growth or better margins), it may be overvalued. Remember that IPO pricing is set by investment bankers (Book Running Lead Managers) who have an incentive to maximise the proceeds for the issuer - and thus to price as high as the market will bear.

The promoter and management background matters significantly. SEBI mandates extensive disclosures about the promoter group, including any previous litigations, regulatory actions, and financial backgrounds. A promoter group with a track record of building businesses and treating minority shareholders fairly is a positive indicator. Conversely, a history of related-party transactions, regulatory penalties, or frequent changes in management is a warning sign.

Subscription data, once available during the IPO window, provides meaningful (though imperfect) signals. QIB (Qualified Institutional Buyer) subscription is watched closely because QIBs - mutual funds, foreign portfolio investors, insurance companies, and other sophisticated institutions - conduct their own due diligence. Strong QIB subscription (though it does not guarantee listing performance) indicates that professional investors find the issue attractive. However, always remember that institutional investors also have their own constraints, mandates, and short-term pressures that can lead them to subscribe for reasons unrelated to long-term value.

Anchor investor disclosures, published by the exchange the day before the IPO opens, reveal which institutional investors were allocated anchor allotments. The quality and diversity of anchor investors is sometimes viewed as a quality signal, though it must be analysed in context.

Finally, consider the macroeconomic and sector context. Is the sector the company operates in in a growth phase? Are there regulatory tailwinds or headwinds? What is the competitive landscape? These factors will influence the company's performance long after the listing day excitement has faded.

Psychological Traps: How GMP Exploits Investor Behaviour

Understanding why GMP has such a hold on retail investor decision-making requires a brief look at the behavioural finance principles at play. Several well-documented cognitive biases make investors particularly susceptible to over-relying on GMP.

Social proof is one of the most powerful. When investors see that "everyone" in their WhatsApp group is excited about an IPO because of its high GMP, and when they see that the IPO is massively oversubscribed, they feel that the crowd must know something they don't. This herd mentality - following the crowd to avoid the regret of missing out - is a classic social proof bias. Grey market operators and promoters of dubious IPOs have been known to exploit this by artificially inflating GMP and creating buzz to generate FOMO (Fear of Missing Out) among retail investors.

Anchoring is another relevant bias. Once an investor sees a GMP figure of, say, ₹300, they anchor their expectations of the listing price to that number. Even if GMP subsequently falls to ₹80 in the days before listing, they mentally discount the fall and still expect a strong listing because their reference point is ₹300. This anchoring to an earlier, higher GMP leads to overconfidence and poor risk management.

Recency bias causes investors to over-weight recent experiences. If the last three IPOs they applied to based on GMP gave strong listing gains, they assume the next one will too, ignoring the randomness and the changing market conditions that make each IPO a distinct situation.

Confirmation bias leads investors who want to participate in an IPO (perhaps because of brand recognition or sector excitement) to focus on the high GMP as confirmation of their pre-existing view, while ignoring risk factors in the DRHP or concerns about valuation.

The narrative fallacy is particularly potent in the IPO context. IPOs come with compelling stories - new-age technology companies, defence indigenisation plays, green energy transition beneficiaries. These narratives are powerful and emotionally resonant. GMP adds a numerical veneer to the narrative, giving investors a seemingly concrete data point that reinforces the story. In reality, the GMP is no more than a reflection of how many other investors are also captured by the same narrative.

Breaking free from these psychological traps requires conscious effort. Practical steps include committing to always reading at least the key sections of the RHP before applying, setting a personal checklist of financial criteria that an IPO must meet (minimum profitability, maximum P/E relative to peers, etc.), and deliberately seeking out contrarian viewpoints or analytical pieces that critique the IPO's valuation. Treating GMP as entertainment rather than as investment advice is perhaps the most important mindset shift of all.

A Balanced View: What GMP Can and Cannot Tell You

It would be intellectually dishonest to suggest that GMP has absolutely zero informational content. Like any market signal, it has some value when interpreted within its proper limitations. This section offers a balanced view.

What GMP can sometimes indicate: First, very high GMP in combination with strong oversubscription (especially in the QIB category) may signal broad-based investor enthusiasm that could translate into a strong listing. This is not a certainty, but it is a data point. Second, a collapsing GMP in the days before listing - particularly if it turns negative (where grey market participants are expecting the stock to list below the issue price) - can be an early warning signal that something may have changed in the market environment or company-specific perception. Third, the Kostak rate can give retail investors a way to calculate a guaranteed (though grey market) exit, allowing them to assess whether the guaranteed return meets their risk-adjusted expectations.

What GMP cannot tell you: GMP tells you nothing about whether the company is fundamentally sound. It tells you nothing about the long-term prospects of the business or the stock. It does not account for post-listing selling pressure from anchor investors, QIBs, or pre-IPO investors once lock-in periods expire. It does not reflect the views of the most sophisticated long-term investors, who rarely participate in grey market transactions. It cannot predict how the stock will perform three months, six months, or a year after listing.

The appropriate use of GMP, if any, is as one very minor data point among many. An investor who has already done a thorough fundamental analysis of the IPO, assessed the valuation, evaluated the management quality, and formed an independent view on the business might glance at GMP to get a rough sense of sentiment. But the investment decision should be driven entirely by the fundamental analysis, not by the GMP figure.

Investors who have been lucky enough to make money on IPOs by following GMP should be careful not to attribute that success to GMP analysis rather than to the fact that they happened to be investing during a strong bull market where many IPOs listed at a premium regardless of their individual merits. As market conditions change and more sophisticated price discovery occurs - aided by SEBI's ongoing reforms to the IPO process - the easy listing gains that characterised the 2020–2022 IPO boom may not repeat, and GMP-based investment approaches will be exposed as the unreliable strategy they always were.

The fundamental principle bears repeating: invest in businesses, not in listing day sentiment. An IPO is the beginning of a company's life as a public entity, not the end. The real wealth creation - or destruction - happens over the years and decades that follow the listing date, driven by the company's ability to grow its revenues, expand its margins, allocate capital wisely, and treat its shareholders fairly. None of this is reflected in the GMP.

Example

Key benefits

How it works

1. 1
   IPO Subscription Opens

   When a company announces its IPO with a price band on NSE and BSE, grey market operators begin quoting a GMP based on the company's profile, sector sentiment, and pre-IPO buzz from the DRHP.

2. 2
   Subscription Data Flows In

   As the IPO subscription window is open (typically 3 days), real-time oversubscription data published by NSE and BSE is monitored by grey market operators, who adjust GMP upward or downward based on the emerging demand picture.

3. 3
   Grey Market Transactions Are Agreed

   Retail investors and grey market operators enter into informal verbal or messaging-based agreements to buy or sell IPO allotments or applications at the GMP-implied price, with settlement expected around listing day.

4. 4
   Allotment Is Announced

   After the subscription closes, the registrar processes applications and announces allotment (typically on T+1 or T+2). Those who received allotments and have grey market agreements begin preparing for settlement.

5. 5
   GMP Evolves Closer to Listing

   In the days between allotment announcement and listing, GMP continues to fluctuate based on broader market movements, news about the company, and grey market supply-demand dynamics - often diverging significantly from peak GMP.

6. 6
   Listing Day Price Discovery

   On listing day (T+3 from issue close, as per SEBI's current timeline), the stock's price is discovered through the formal pre-open session on NSE and BSE. This is the first real, regulated, transparent price signal - and it frequently differs from GMP.

7. 7
   Grey Market Settlement

   After listing, grey market agreements are settled between parties - either through share delivery at agreed prices or cash settlement of the price difference. Defaults are common when listing prices diverge sharply from GMP, and there is no formal recourse for either party.

Formula

Implied Listing Price (Grey Market) = IPO Upper Price Band + GMP
GMP as % = (GMP ÷ IPO Upper Price Band) × 100

Key takeaways

Frequently asked questions

Related terms